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Colorectal cancer is one of the major causes of
cancer-related deaths. To gain further insights
into the mechanisms underlying its develop-
ment, we investigated the role of Wip1 phos-
phatase, which is highly expressed in intestinal
stem cells, in the mouse model of APCMin-
driven polyposis. We found that Wip1 removal
increased the life span of APCMin mice through
a significant suppression of polyp formation.
This protection was dependent on the p53
tumor suppressor, which plays a putative role
in the regulation of apoptosis of intestinal
stem cells. Activation of apoptosis in stem cells
of Wip1-deficient mice, but not wild-type
APCMin mice, increased when the Wnt pathway
was constitutively activated. We propose,
therefore, that the Wip1 phosphatase regulates
homeostasis of intestinal stem cells. In turn,
Wip1 loss suppresses APCMin-driven polyposis
by lowering the threshold for p53-dependent
apoptosis of stem cells, thus preventing their
conversion into tumor-initiating stem cells.
INTRODUCTION
Colorectal cancer (CRC) is the second largest cause of
cancer-related deaths in Western countries. CRC arises
as a result of stepwise genetic alterations in specific onco-
genes and tumor suppressors. Mutations in the tumor
suppressor adenomatosis polyposis coli (APC) gene,
a gatekeeper gene in CRC tumorigenesis, occur early in
the development of CRC and lead to the stabilization of
b-catenin and constitutive activation of Wnt signaling
(Polakis, 1997). Much of our current knowledge comes
from studies of the hereditary CRC syndrome, familial
adenomatous polyposis (FAP). In FAP, individuals develop
numerous intestinal adenomas relatively early in life that
rapidly progress to carcinomas. In addition, mouse
models of CRC continue to make critical contributions to180 Cell Stem Cell 1, 180–190, August 2007 ª2007 Elsevier Incour understanding of the molecular mechanisms underly-
ing this multistage disorder. Mice mutant for APC, similar
to the defect in FAP patients and in many sporadic can-
cers, mimic the rapid development of adenomatous
polyps that affects humans with germline inactivation of
one APC gene (Su et al., 1992). ApcMin/+ mice have a non-
sense mutation at codon 850 in the Apc gene that results
in a truncated protein product, and these mice are predis-
posed to form intestinal tumors. In ApcMin/+ mice, tumors
arise as a result of loss of heterozygosity (LOH) at Apc as
well as through LOH-independent mechanisms (Reitmair
et al., 1996).
Accumulating evidence supports a role for stem cells in
tumorigenesis, including CRC, and several intestinal stem
cell markers are highly expressed in APCMin adenomas
and carcinomas (O’Brien et al., 2007; Ricci-Vitiani et al.,
2007; Van der Flier et al., 2007). In turn, targeting stem
cells during their conversion into cancer stem cells repre-
sents a powerful yet unexploited cancer-prevention tool.
The problem, however, is in detecting intestinal stem cells
and thus analyzing their behavior. Self-renewal and organ
development assays are not possible with intestinal stem
cells; however, their position within the crypt is well de-
fined (Marshman et al., 2002; Potten and Ellis, 2006).
There are 4–6 stem cells at the crypt base (positions 4–
6) that normally divide once a day, producing a pool of
proliferative progenitors that differentiate while moving
up the crypt in a continuous wave to be shed after a total
lifetime of about 5–7 days (Potten and Ellis, 2006). One of
the remarkable features of intestinal stem cells is that, de-
spite their large number and rapid rate of cell division,
these cells rarely acquire the age-related genetic defects
associated with cancer induction or show deterioration
in functional competence. This observation suggests
that intestinal stem cells have evolved protective mecha-
nisms against genetic damage. Among them is the ability
of stem cells to selectively sort the old (parental) and new
DNA strands when they divide, retaining only parental
DNA strands (Potten et al., 2002). This phenomenon is
called asymmetric division and ensures that replication-
induced errors are excluded from stem cells. Random
errors introduced into parental strands (e.g., after expo-
sure to genotoxic agents) trigger a second protective.
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(Merritt et al., 1994). Conceivably, alteration of either
mechanism could expedite tumorigenesis or, conversely,
serve as a powerful cancer-prevention tool.
The Wip1 phosphatase is emerging as a potent regula-
tor of tumorigenesis through its ability to attenuate the
activity of several stress-induced kinases (Demidov
et al., 2007; Shreeram et al., 2006a; Nannenga et al.,
2006; Lu et al., 2005; Fujimoto et al., 2006). We previously
found that deletion of Wip1 results in a dramatic delay in
the onset of mammary gland tumors and lymphomas in
cancer-prone mouse strains (Bulavin et al., 2004;
Shreeram et al., 2006b). In turn, ApcMin/+ mice have
been instrumental in colon cancer studies (Corpet and
Pierre, 2003); however, the molecular events involved in
neoplasia in CRC have only been partially characterized.
We therefore chose this in vivo tumor model to analyze
the role of Wip1 in the initiation and progression of intesti-
nal cancer. We found that Wip1 phosphatase modulates
APCMin-driven polyposis by setting a threshold for p53-
dependent apoptosis of stem cells, thus preventing their
conversion into tumor-initiating/cancer stem cells.
RESULTS
Expression of Wip1 Phosphatase in Mouse Intestine
To determine the distribution of Wip1 in the mouse intes-
tine, we analyzed Wip1 mRNA expression using in situ
hybridization and found positively stained cells within the
crypt base (Figure 1A and see Figure S2 in the Supple-
mental Data available with this article online). Analysis of
the cell position along the crypt axis indicated that Wip1
mRNA-positive cells were predominantly in position 4
from the crypt base. To further characterize Wip1-
expressing cells, we performed an immunohistochemical
analysis using a polyclonal antibody to Wip1 (Fujimoto
et al., 2006). We found the majority of Wip1-positive cells
were in position 4, with the long tail to the right (Figure 1A,
right panels).
Stem/early progenitor cells occupy positions 4–6 in the
intestine, whereas Paneth cells occupy the first three
positions (Potten et al., 2002; Potten and Ellis, 2006). To
further characterize Wip1-expressing cells, we used anti-
bodies to phospho-PTEN, a recently identified intestinal
stem cell marker (He et al., 2004, 2007). Consistent with
previous data (He et al., 2004, 2007), we found that the
phospho-PTEN antibody predominantly stained cells in
stem cell positions 4–6 from the base of the crypt
(Figure 1B and Figure S2). Next, we performed dual immu-
nohistochemical staining of Wip1 and phospho-PTEN and
found coexpression of these two markers (Figure 1C).
As has been established in the field, the approach to
analyze adult stem cells is to perform label-retaining
experiments using either [3H]thymidine or BrdU (Radtke
and Clevers, 2005; Potten et al., 2002; Waikel et al.,
2001; Welm et al., 2002; Urbanek et al., 2006). In the
mouse intestine, label-retaining experiments have been
supported by experiments using ionizing radiation (IR),
which provides a surrogate repopulation (organ develop-Cement) test. It has been established that label-retaining
cells are the most sensitive cells to IR and that the extent
to which these cells are killed by IR is reflected in the intes-
tinal morphology (reviewed in Potten and Ellis, 2006).
Furthermore, the death of label-retaining cells affects
crypt survival in the mouse intestine. The above data con-
firm that label-retaining cells are intestinal stem cells. To
rigorously test whether Wip1-positive cells are indeed
intestinal stem cells, we next carried out juvenile label-
retaining experiments using [3H]thymidine (Potten et al.,
2002). This protocol labels proliferating cells, including
stem cells. In the intestine, almost all labeled cells are
removed due to continuous flow up the crypt, where
they are shed in the intestinal lumen. Two features of
stem cells allow them to retain [3H]thymidine. First, stem
cells do not migrate but continue to reside in the intestine
and, once labeled, are easy to detect. Second, even when
they divide, intestinal stem cells retain the labeled parental
strands of DNA, thus preventing [3H]thymidine-labeled
DNA from being diluted during multiple rounds of division
(Potten et al., 2002). We injected 5- to 6-week-old wild-
type mice with 50 mCi [3H]thymidine every 12 hr for
3 days and sacrificed them 3weeks after the last injection.
Consistent with previous reports (Potten et al., 2002;
Potten and Ellis, 2006), we found [3H]thymidine-retaining
cells predominantly in position 4 from the crypt base
(Figure 1D). Subsequent costaining for Wip1 revealed
that the majority of [3H]thymidine-retaining cells were
positive for Wip1 (Figure 1D, right panel), supporting the
idea that Wip1 is specifically expressed in intestinal
stem cells.
It is important to emphasize that our data do not exclude
the possibility that Wip1-expressing stem cells could be
found in the Paneth cell area. As shown in Figures 1A
and 1D, about 40% of cells in the Paneth cell compart-
ment retain [3H]thymidine and express Wip1 mRNA.
Thus, our data are compatible with the hypothesis that
some intestinal stem cells reside in the Paneth area
(Bjerknes and Cheng, 2006).
Expression of Wip1 phosphatase after DNA damage is
dependent on the p53 tumor suppressor (Choi et al.,
2002; Fiscella et al., 1997). To investigate whether intesti-
nal Wip1 expression is regulated through p53, we carried
out an immunohistochemical analysis of Wip1 in the intes-
tines of p53 null mice. Compared to wild-type mice, Wip1
was present in p53 null intestines at similar levels and in
similar cell positions within the crypt base (Figure 1E).
Thus, Wip1 expression is regulated in a p53-independent
manner in mouse intestinal stem cells.
Wip1 Phosphatase Regulates
APCMin-Induced Polyposis
To understand the potential role of Wip1 in regulating
intestinal tumorigenesis and in ApcMin/+-driven polyposis
in particular, we next carried out real-time PCR analysis
of Wip1 mRNA in polyps and compared it with Wip1
mRNA levels in normal intestinal epithelium. Total RNA
was purified from intestinal epithelium and microdis-
sected polyps, both obtained from APCMin mice, andll Stem Cell 1, 180–190, August 2007 ª2007 Elsevier Inc. 181
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(A) Wip1 mRNA and protein expression (shown with arrowheads) was analyzed in intestine sections obtained from wild-type mice using in situ RNA
hybridization (left panel) and immunohistochemistry with an antibody to Wip1 (right panel). The Paneth cells were counterstained with an antibody to
lysozyme. The number and position of Wip1-positive cells within the crypt base were plotted.
(B) Phospho-PTEN-positive cells were identified using an antibody specific for phospho-PTEN, and the number and position of phospho-PTEN-
positive cells (shown with arrowhead) within the crypt base were plotted. The area containing Paneth cells is outlined.
(C) Two consecutive intestine sections were stained for Wip1 (left) or phospho-PTEN (right) and merged. Positively stained cells are shown with
arrowheads.
(D) Label-retaining experiments were carried out using juvenile wild-type mice as described in the Experimental Procedures. The position of [3H]thy-
midine-retaining cells was counted, and slides were counterstained for Wip1 (right panel). Label-retaining cell is shown with arrowhead. The Paneth
cell area is outlined.
(E)Wip1 protein expression was analyzed in p53 null mouse intestines, and the number and the position ofWip1-positive cells (shownwith arrowhead)
within the crypt base were plotted. The area containing Paneth cells is outlined.used for reverse transcription and subsequent real-time
PCR analysis. The level of Wip1 mRNA in polyps was
5-fold greater than in intestinal epithelium (Figure 2A).
The Wip1 mRNA overexpression in polyps of APCMin
mice was further confirmed by in situ RNA hybridization
(Figure 2B).
It is possible that accumulation of Wip1 in polyps in the
course of APCMin-driven polyposis is a consequence of
cancer progression rather than a contributing factor. To
investigate this possibility, ApcMin/+ mice were crossed
with Wip1 null mice, and then we intercrossed Wip1+/
mice carrying the ApcMin/+ allele to yield two genotypes:182 Cell Stem Cell 1, 180–190, August 2007 ª2007 Elsevier IncWip1+/+ andWip1/mice, all carrying the ApcMin/+ allele.
To investigate tumor onset, we used only littermates from
the same parents for all crosses. We found that Wip1/
mice survived longer than wild-type (WT)/ApcMin/+ mice
(Figure 2C) and developed only a few polyps by day 120
(Figure 2D, 8 ± 1 polyps per mouse for Wip1 null/ApcMin/+
compared to 67 ± 5 polyps per mouse for WT/ApcMin/+,
p < 0.001). Moreover, Wip1 null/ApcMin/+ mice that sur-
vived beyond 300 days developed only 18 ± 1 polyps
per mouse, which was statistically insignificant from the
number of polyps developed by day 120 (8 ± 1 polyps per
mouse). Polyp analysis showed that Wip1 null/ApcMin/+.
Cell Stem Cell
Wip1/p53-Dependent Apoptosis of Intestinal Stem CellsFigure 2. Wip1 Phosphatase Regulates APCMin-Induced Polyposis
(A) Expression of Wip1 mRNA in normal intestinal epithelium and in microdissected polyps was analyzed using quantitative real-time PCR.
(B) Wip1 mRNA levels were analyzed using in situ hybridization in APCMin mice. The polyp area is outlined.
(C) Survival of APCMin and APCMin/Wip1 null mice over a period of 300 days.
(D) The number of polyps in APCMin and APCMin/Wip1 null mice at 120 days.
(E) The size distribution of polyps in APCMin and APCMin/Wip1 null mice at 120 days.
(F) The distribution of polyps in APCMin and APCMin/Wip1 null mice in different compartments of the mouse intestine.polyps were smaller in size than WT/ApcMin/+ polyps (p =
0.05) and were primarily localized to the small intestine
(Figures 2E and 2F). Thus, Wip1 deficiency dramatically
suppresses polyp formation in the presence of the ApcMin
mutation, supporting the idea that Wip1 is critical in
regulating ApcMin-driven polyposis.
Increased Intestinal Stem Cell Apoptosis in Wip1
Null Mice
Activation of the b-catenin signaling pathway is critical for
polyp development through Tcf/Lef-dependent gene
regulation (Korinek et al., 1997; Morin et al., 1997). To
determine whether b-catenin activation was impaired in
Wip1 null mice, immunohistochemical analysis was used
to determine its subcellular localization. Although polyps
that developed in Wip1 null/ApcMin/+ mice were substan-
tially smaller than in WT/ApcMin/+ mice (Figure 3A, top
panels), b-catenin was detected in the nuclei of polyp cells
of both genotypes (Figure 3A, bottom panels). This
suggests that Wip1 deficiency does not affect nuclear
accumulation of b-catenin. Once b-catenin accumulates
in the nucleus, it induces the transcription of Tcf/Lef-
dependent genes. We observed increased expression of
these genes in the intestines of ApcMin/+ mice compared
to wild-type mice (Figure 3B). A similar increase in
mRNA levels for c-myc, cyclin D1, CD44, and Brachyury
was found in Wip1 null/ApcMin/+ compared to Wip1 null
intestines, with no apparent difference between WT/CeApcMin/+ and wild-type mice, respectively. Thus, defi-
ciency of Wip1 does not affect the b-catenin-Tcf/Lef-
dependent signaling pathway.
Wip1 null mice show a profound tumor-resistant pheno-
type in several mouse models of cancer (Bulavin et al.,
2004; Shreeram et al., 2006b). To determine how polyp
formation is suppressed in Wip1 null/ApcMin/+ mice
(Figure 2D), we next analyzed cell proliferation and apo-
ptosis in the intestine. Analysis of cell proliferation based
on BrdU incorporation experiments revealed no difference
between Wip1 null/ApcMin/+ and WT/ApcMin/+ mice where
proliferative cells were restricted to the crypt compart-
ment in both genotypes (Figure 3C). Similar results were
obtained with another marker of proliferation, Ki-67 (data
not shown). We also observed similar migration of BrdU-
pulse-labeled epithelial cells in both WT/ApcMin/+ and
Wip1 null/ApcMin/+ mice (data not shown). Analysis of ap-
optosis using an antibody to the active form of caspase-3
revealed positively stained cells in positions 4–6 from the
base of the crypt in Wip1 null/ApcMin/+ mice, while only
a few positive cells were observed in WT/ApcMin/+ mice
(Figures 4A and 4B).
Self-renewal and organ development assays are not pos-
sible in the intestine as they are in other organs such as
breast, prostate, or the hematopoietic system; however,
thespatial organizationof intestinal stemcells iswelldefined
and documented (Potten and Ellis, 2006; Marshman et al.,
2002; Clevers, 2006). A series of elegant experimentsll Stem Cell 1, 180–190, August 2007 ª2007 Elsevier Inc. 183
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(A) Polyps from APCMin and APCMin/Wip1 null mice at 120 days were analyzed after staining with hematoxylin and eosin (H&E; area of intramuscular
tumor growth is shown with arrowhead) or with anti-b-catenin antibody (bottom panels). Nuclear staining was observed for b-catenin in the polyps of
both APCMin and APCMin/Wip1 null mice.
(B) mRNA levels of Tcf/Lef-dependent genes were analyzed in the intestines of wild-type, APCMin, Wip1 null, and APCMin/Wip1 null mice using real-
time PCR. Error bars represent the standard deviation of triplicate experiments.
(C) Intestinal epithelium proliferation was analyzed after a 2 hr pulse with BrdU.confirmed that intestinal stem cells are located in positions
4–6 from the base of the crypt, and several markers were
characterized in these cells, including phospho-PTEN,
Sox4, and Ascl2 (He et al., 2004; Van der Flier et al., 2007).
As we found apoptotic cells in positions 4–6 in Wip1 null
mice (Figure 4A and Figure S2), we next carried out double
labeling to analyze markers of apoptosis and markers of
intestinal stem cells, Sox4 and Ascl2, by RNA in situ hybrid-
ization (Figures 4D and 4E and Figure S2). We also used
immunohistochemistry to analyze whether TUNEL-positive
cells colocalized with another marker of intestinal stem
cells, phospho-PTEN (Figure 4C). We found that 80% of
apoptosis-positive cells showed costaining with either
Sox4, Ascl2, or phospho-PTEN.We next counted the num-
ber of positive cells for different markers according to their
position along the crypt axis, as previously described (Pot-
ten et al., 2002). The cell position frequency plot showed
that stem cell markers such as Sox4, Ascl2, and phospho-
PTEN, as well as apoptotic cells analyzed in sections from
Wip1 null mice, peaked at cell position 4 (Figures 1B, 4A,
4D, and 4E). Similar frequency plots were obtained for
stem cell markers in wild-type mice (data not shown).184 Cell Stem Cell 1, 180–190, August 2007 ª2007 Elsevier IncTo unambiguously confirm that some intestinal stem
cells undergo apoptosis in Wip1 null mice, we carried
out a label-retaining experiment using juvenile mice
(Potten et al., 2002). We found that cells undergoing
apoptosis also retained [3H]thymidine (Figure 4F). These
data strongly support the idea that intestinal stem cells
in Wip1 null/ApcMin/+mice undergo apoptosis. Consistent
with the hypothesis that some intestinal stem cells reside
in the Paneth area (Bjerknes and Cheng, 2006), we found
that about 40%of cells in the Paneth cell compartment are
reactive for the stem cell markers Sox4, Ascl2, and phos-
pho-PTEN, retain [3H]thymidine, and undergo apoptosis in
Wip1 null mice (Figure 4).
There is a low level of spontaneous apoptosis of intesti-
nal stem cells in APCMin-Wip1 null mice (Figures 4A and
4B). This is different from a massive cell death of intestinal
stem cells after IR, which leads to a compensatory
increase in the number of proliferative cells in the crypt
compartment (Potten et al., 1995). In turn, the death of
a few intestinal stem cells, as in Wip1 null mice (Figures
4A and 4B), is not detrimental to the function of the partic-
ular crypt as these cells couldbe easily replacedwith either.
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Wip1/p53-Dependent Apoptosis of Intestinal Stem CellsFigure 4. Wip1 Deficiency Results in Intestinal Stem Cell Apoptosis
Apoptosis in the intestines of mice was detected using either the TUNEL assay ([A], indicated with arrowhead) or an antibody to active caspase-3 (B).
The Paneth cells were counterstained using RNA in situ hybridization to visualize MMP7. Cross-sections of intestines from APCMin/Wip1 null mice
were analyzed for stem cell markers phospho-PTEN (C), Sox4 (D), or Ascl2 (E). Apoptotic cells were stained with TUNEL (indicated with arrowheads).
The area containing Paneth cells was identified based on the visual identification of cell-specific granules and is outlined on each image. (F) Label-
retaining experiments were carried out with juvenile Wip1 null mice, and slides were counterstained for apoptosis. High-magnification figure (right
panel) shows a TUNEL-positive cell in position 4 containingmultiple grains of incorporated [3H]thymidine. (G)Wild-type andWip1 null mice were pulse
labeled with BrdU, and the numbers of BrdU-positive cells in the crypts that either had or did not have apoptotic stem cells were counted. Apo (–)
stands for crypts without apoptotic stem cells; Apo (+) stands for crypts with apoptotic stem cells. At least 50 crypts were counted for each group.
(B and G) Error bars represent the standard deviation of triplicate experiments.early proliferative progenitors or another stem cell (dis-
cussed below). Thus, it is conceivable to see no compen-
sation in proliferation in the crypt progenitor compartment
of Wip1 null intestine (Figure 3C). To further verify this, we
counted BrdU-positive cells in the crypts that either had or
did not have apoptotic stem cells in Wip1 null mice and
compared the numbers with wild-type mice. As shown in
Figure 4G, we found no difference in the number of
BrdU-positive cells between different groups.
p53 Tumor Suppressor Protects Wip1 Null Mice
from APCMin-Induced Polyposis
To investigate themolecular mechanisms that causeWip1
null mice to be resistant to ApcMin-driven polyposis, we
investigated the expression of cell-cycle control/apopto-
sis proteins in extracts from the intestines of mice withCedifferent genotypes (Figure 5A). While no difference was
observed in expression of b-catenin, Cox-2, p27Kip1,
p16Ink4a, p19Arf, and cyclin D1 between WT/ApcMin/+
(lane 2) and Wip1 null/ApcMin/+(lane 4) intestines, the level
of expression of the p53 tumor suppressor and its down-
stream target, p21Waf1, was increased inWip1 null tissues.
To understand the contribution of p53 to p21Waf1 activa-
tion, we next crossed Wip1 null/ApcMin/+ mice with p53
null mice, and subsequently intercrossed either p53-het/
ApcMin/+ or Wip1 null/p53-het/ApcMin/+ mice, to yield
four genotypes: ApcMin/+ and p53 null/ApcMin/+; Wip1
null/ApcMin/+ and Wip1 null/p53 null/ApcMin/+. Next, we
purified intestinal crypts from 8- to 12-week-old mice,
confirmed the presence of the crypt base by analyzing
lysozyme-positive (Paneth) cells (Figure S1), and analyzed
protein expression by western blotting. We found thatll Stem Cell 1, 180–190, August 2007 ª2007 Elsevier Inc. 185
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(A) The indicated antibodies were used to analyze proteins in extracts from the ileums of wild-type, APCMin, Wip1 null, and APCMin/Wip1 null mice.
(B) Protein expression was analyzed in intestinal crypts purified from 4- to 6-week-old APCMin, APCMin/Wip1 null, APCMin/p53 null, and APCMin/p53
null/Wip1 null mice.
(C) The number of polyps in APCMin, APCMin/p53 null, and APCMin/p53 null/Wip1 null mice were counted at 90 days.both p53 and p21Waf1 were upregulated (2 and 6 fold,
respectively) in epithelial cells obtained from Wip1 null/
ApcMin/+mice compared toWT/ApcMin/+mice (Figure 5B).
In turn, removal of p53 eliminated the difference in p21Waf1
expression levels between the different genotypes,
supporting the idea that expression of p21Waf1 is regulated
in a p53-dependent manner in Wip1 null intestinal
epithelium.
To understand the contribution of p53-dependent
signaling pathways in suppressing ApcMin-driven polypo-
sis in Wip1 null mice, we next analyzed polyp formation in
mice of different genotype: ApcMin/+ and p53 null/ApcMin/+
(one group of littermates), Wip1 null/ApcMin/+ and Wip1
null/p53 null/ApcMin/+ (another group of littermates). For
this set of experiments, we counted polyps at 90 days,
because the majority of p53 null mice rapidly succumb
to cancer (primarily lymphomas) later in life (Donehower
et al., 1992). We found that the deletion of p53 caused
an outbreak of polyp formation in Wip1/p53 null/ApcMin/+
mice (49 ± 6 polyps for Wip1/p53 null/ApcMin/+ versus
7 ± 3 polyps per mouse for Wip1 null/ApcMin/+ mice
[Figure 5C]). Thus, p53 is important in rendering Wip1
null mice resistant to polyposis.
Activation of Wnt-Dependent Signaling Drives
Apoptosis of Wip1 Null Intestinal Stem Cells
The p53 tumor suppressor plays a primary role in regulat-
ing cell-cycle arrest and apoptosis (Wilson et al., 1998;
Christophorou et al., 2006; Oren, 2001). In turn, activation
of p53 could sensitize intestinal stem cells to DNA186 Cell Stem Cell 1, 180–190, August 2007 ª2007 Elsevier Incdamage-induced apoptosis caused by IR, which would
explain why intestinal stem cells are efficiently killed in
a p53-dependent manner at a dose as low as 0.01 Gy of
IR (Ishizuka et al., 2003). Homozygous loss of wild-type
APC results in constitutive activation of the Wnt/b-catenin
signaling pathway; this could trigger, as does IR, an
efficient p53 response that promotes apoptosis (Damalas
et al., 1999; Sansom et al., 2004). To investigate how
activation of b-catenin signaling modulates stem cell
behavior, we next treated WT/ApcMin/+ and Wip1 null/
ApcMin/+ mice with specific inhibitors of GSK, a kinase
that induces phosphorylation-dependent degradation of
b-catenin (Salic et al., 2000). In both genotypes, inactiva-
tion of GSK with different chemical inhibitors resulted in
upregulation of Tcf/Lef-dependent genes such as cyclin
D1 (p = 0.026), myc (p = 0.042), and CD44 (p = 0.033)
(Figure 6A). Further analysis revealed that the intestinal
stem cells of Wip1 null/ApcMin/+mice exhibited significant
apoptosis after treatment with GSK inhibitors IX (p =
0.021), X (p = 0.016), and XIII (p = 0.042), while no changes
were observed in WT/ApcMin/+ mice (Figure 6B). Further-
more, both spontaneous apoptosis and GSK inhibitor IX-
induced apoptosis of stem cells were completely
abrogated after deletion of p53 in Wip1 null/ApcMin/+
mice (Figure 6B). Similar results were obtained with GSK
inhibitors X and XIII (data not shown). These data further
support the idea that activation of the b-catenin signaling
pathway triggers efficient apoptosis of intestinal stem
cells under conditions in which the level of p53 is already
attenuated, as in Wip1 null mice..
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The architecture of the intestine represents a unique anti-
cancer barrier, as potential tumor-promoting DNA lesions
caused by carcinogens and/or mutagens (consumed with
food or by-products from bacterial load) do not pose
a threat of tumor formation (Potten and Ellis, 2006). These
damaged cells are efficiently removed from the intestine
due to the continuous flow of epithelial cells from the
base of the crypt to the tip of the villus (Clevers, 2006).
Intestinal stem cells, which are located in positions 4–6
from the crypt base and in the Paneth area (Potten et al.,
2002; Potten and Ellis, 2006; Bjerknes and Cheng,
2006), are the only type of continuously dividing cell that
escapes this flow. Thus, it is conceivable that molecular
changes that ultimately contribute to CRC may originate
within these cells (Sancho et al., 2004). The stem cell origin
of CRC is further supported by the fact that several
intestinal stem cell markers were found to be abundant
in APCMin adenomas and carcinomas (Van der Flier
et al., 2007). Once a stem cell acquires a cancer-promot-
ing genetic change, however, it is converted into a cancer
Figure 6. Constitutive Activation of b-Catenin Signaling
Results in Apoptosis of Intestinal StemCells inWip1Null Mice
(A) WT/ApcMin/+ and Wip1 null/ApcMin/+ mice were injected with three
different inhibitors of GSK (IX, X, and XIII, Calbiochem), and the level of
expression of TCF/Lef-dependent genes was analyzed 10 hr later by
real-time PCR.
(B) Analysis of apoptosis in the intestine of different genotypes 6 hr
after injection of GSK inhibitor IX was carried out using an antibody
to active caspase-3.
Error bars represent the standard deviation of triplicate experiments.Cestem cell that subsequently gives rise to polyps and, even-
tually, to more advanced cancers.
Accumulating evidence supports the role of stem cells
in tumorigenesis (Leedham et al., 2005; O’Brien et al.,
2007; Ricci-Vitiani et al., 2007). This would ultimately
require their conversion into cancer stem cells in the
course of tumorigenesis, a task that stem cells are pro-
hibited to fulfill due to their nature. Stem cells, and intesti-
nal stem cells in particular, while dividing continuously
during their lifespan, show little evidence of any decline
in the proliferation potential yet rarely develop carcino-
genic mutations, suggesting that their genome is
extremely well protected (Potten et al., 2002). This protec-
tion is achieved by several mechanisms, including their
ability to selectively sort old (parental) and newly synthe-
sized strands of DNA, a process called asymmetric divi-
sion (Morrison and Kimble, 2006). If this mechanism fails,
stem cells are further protected against acquiring changes
in their genome by undergoing apoptosis when such
errors occur (Potten et al., 2002). These two processes
could be interconnected, as the inability to undergo effi-
cient repair process (as a part of asymmetric division)
could explain high sensitivity of stem cells to genotoxic
damage because some repair enzymes would be com-
mon to both processes. In turn, modification of either
mechanism could expedite tumorigenesis or serve as
a powerful cancer-prevention tool, as demonstrated
here in Wip1 null mice.
If cancer originates in a stem cell (Leedham et al., 2005;
O’Brien et al., 2007; Ricci-Vitiani et al., 2007), certain
genetic alterations observed in the early stages of cancer
should be traceable back to a particular stem cell. In the
case of the APCMin-induced model of polyposis, Apc+
allelic loss was detected in all lesions examined by Levy
et al. (1994), who observed inactivation even in the earliest
recognizable phase of tumors. Thus, the loss of the wild-
type APC allele in APCMin mice that is observed in all
polyps could originate in a single stem cell. In turn, once
the stem cell acquires both mutant APC alleles, it will
constitutively activate the b-catenin signaling pathway,
triggering activation of Tcf/Lef-dependent genes as well
as p53 (Damalas et al., 1999). Such activation of p53 in
wild-type stem cells is well tolerated (Figure 6B); however,
in a situation in which p53 is already elevated (as in Wip1
null cells), it induces apoptosis. Similarly, very small doses
of radiation induce marked p53-dependent (ATM-inde-
pendent) apoptosis, which is enhanced in a Wip1 null
background, supporting the idea that intestinal stem cells
are very sensitive to p53 activation (Merritt et al., 1994;
Potten, 1977; Potten and Grant, 1998). Once a stem cell
is destroyed, however, the asymmetric sister cells (the first
or second early progenitor) replace it and assume the
functions of a stem cell in repopulating the crypt (Martin
et al., 1998). At this early stage in their lineage develop-
ment, the asymmetric sister cells appear to retain stem
cell properties (Potten and Ellis, 2006; Morrison and
Kimble, 2006). Alternatively, symmetric division of a neigh-
boring stem cell could replace a destroyed stem cell,
because there are 4–6 stem cells per crypt (Potten andll Stem Cell 1, 180–190, August 2007 ª2007 Elsevier Inc. 187
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mechanism, i.e., apoptosis, could be critical for prevent-
ing stem cells from converting into tumor-initiating/cancer
stem cells and giving rise to intestinal cancer once the
wild-type APC allele is lost and the b-catenin pathway is
constitutively activated to drive polyposis. In conclusion,
we show that the Wip1 phosphatase, which is highly
expressed in the intestinal stem cells, regulates homeo-
stasis of these cells, especially under stress conditions
such as the presence of oncogenes. In turn, Wip1 loss
suppresses APCMin-driven polyposis by setting a thresh-
old for p53-dependent apoptosis of stem cells, thus




All animal protocols used in this studywere approved by the Institute of
Molecular and Cell Biology Animal Safety and Use Committee. Wip1
null (129Sv-C57BL/6 background) and p53 null (C57BL/6 background)
mice were previously described (Donehower et al., 1992; Choi et al.,
2002). APCMin heterozygous (C57BL/6J background) mice were ob-
tained from the Jackson Laboratory. We crossed Wip1+/ mice with
APCMin and p53+/ mice to obtain mice of different genotypes. Mice
were euthanized and polyps were counted at 90, 120, and 300 days.
Immunohistochemistry
Formalin-fixed paraffin-embedded mouse intestinal samples were
sectioned at 5 mm and mounted on coated slides. Following dewaxing
and hydration, sections were pretreated with peroxidase blocking
buffer (3% H2O2 in methanol) for 20 min at room temperature (RT).
Antigen retrieval was performed by autoclaving samples in Na-citrate
buffer (10 mM, pH 6.0) for 30 min. Blocking of nonspecific binding was
performed using 3%BSA or 5% blocking reagent (Roche) for 30min at
RT. All antibodies were incubated overnight at 4C. The following
antibodies were used: rabbit anti-lysozyme (1:150; DAKO); rabbit
anti-caspase-3 (1:300) (AF835 R&D); anti-Wip1 antibody (Fujimoto
et al., 2006); anti-p-PTEN (Ser380) antibody (1:25) (Cell Signaling Tech-
nology, Danvers, MA, USA); and goat anti-b-catenin (1:50; Santa Cruz,
C-18). The BrdU staining kit (Zymed) and In Situ Cell Death Detection
Kit (Roche) were used for BrdU staining and TUNEL assay, respec-
tively. In all cases, the Envision+ kit (DAKO) was used as a secondary
reagent. For goat anti-b-catenin antibodies, a bridge step using rabbit
anti-goat antibodies was required. Staining was developed using DAB
and counterstaining with hematoxylin.
For simultaneous staining of BrdU and active caspase-3, formalin-
fixed tissue sections were deparaffined by passing through Xylene,
10 min 3 3; 100% ethanol, 2 min 3 2; 95% ethanol, 2 min 3 1; 70%
ethanol, 2 min 3 1; and distilled water, 2 min 3 3. Unmasking of
epitope was accomplished using 10 mM citrate buffer (pH 6.0) at
121C for 20 min in autoclave and subsequent DNase I (20 U/ml,
NEB, Beverly, MA, USA) treatment for 30 min at 37C. After DNase
treatment, sections were washed with PBS, blocked with 2% BSA/
PBS, and incubated with primary mouse monoclonal antibodies
against BrdU (1:50) (BD Biosciences, San Jose, CA, USA) and rabbit
polyclonal against active form of caspase-3 (1:200) (R&D Systems
[AF835], Minneapolis, MN, USA) overnight at 4C. After three washes
with PBS, secondary anti-mouse Alexa 594 and anti-rabbit Alexa
488 antibodies (1:500) (Invitrogen Molecular Probes, Eugene, OR,
USA) were applied for 1 hr at RT.
For simultaneous staining of TUNEL and PTEN, Carnoy’s fixed tis-
sue sections were deparaffined and microwaved in 100 mM citrate
buffer (pH 6.0) at low power level for 4 min and rinsed three times
with PBS, and TUNEL-positive cells were visualized with In Situ Cell188 Cell Stem Cell 1, 180–190, August 2007 ª2007 Elsevier Inc.Death Detection Kit (Fluorescein) (Roche Applied Bioscience, Man-
heim, Germany). Sections were washed three times with PBS, blocked
with 2% BSA/PBS, and incubated with anti-p-PTEN (Ser380) antibody
(1:25) (Cell Signaling Technology, Danvers, MA, USA) overnight at 4C.
After three washes with PBS, secondary anti-rabbit-Alexa 594 anti-
bodies (1:500) (Invitrogen Molecular Probes, Eugene, OR, USA) were
applied for 1 hr at RT. Vectashield mounting media with DAPI (Vector-
Laboratories, Burlingame, CA, USA) was used to mount slides for
subsequent analysis by Olympus BX61 microscope.
In Situ mRNA Hybridization
Partial Mmp7, Ascl2, and Sox4 cDNAs were obtained by RT-PCR from
total mouse RNA, and T7 promoter was added by additional PCR
(primer sequences are available upon request). Probes were synthe-
sized by in vitro transcription using MEGAscript T7 kit (Ambion) and
DIG RNA labeling mix (Roche). Formalin-fixed paraffin-embedded
mouse intestinal samples were sectioned at 5 mm and mounted on
coated slides. Following standard dewaxing and hydration, samples
were treated with 0.2 N HCl for 20 min at RT. The RNA in situ hybrid-
ization was performed using the mRNA Locator Kit (Ambion) protocol.
Dig-labeled cRNA probes (500 ng/ml) were diluted in hybridization
solution and hybridization was performed during 48 hr at 68C. Detec-
tion of probe was achieved with sheep anti-digoxigenin Fab (Roche)
conjugated to alkaline phosphatase (1/5000 in PBS/blocking powder;
overnight at 4C). Alkaline phosphatase activity was revealed with
NBT/BCIP.
Real-Time RT-PCR
mRNA expression was determined by real-time-PCR. Tissues were
frozen in dry ice, and RNA was extracted using the TRIzol reagent (In-
vitrogen). Reverse transcription was performed using Superscript II
(Invitrogen) according to the manufacturer’s instructions. Real-time
PCR was performed by LightCycler 2.0 Real-Time PCR System
(Roche) with LightCycler FastStart DNA MasterPlus SYBR Green I
(Roche). GAPDH and HRPT mRNA levels were used as a reference.
Primers were designed using the Primer3 program (Rozen and Skalet-
sky, 2000). Ppm1d 50-CAGAAAGGCTTCACCTCGTC-30; 50-CACCT
CCACAGCTCTCACAA-30. Brachyury 50-TCCCGAGACCCAGTTCAT
AG-30 and 50-TGACCGGTGGTTCCTTAGAG-30; Ccn1d 50-ACCGCAC
AACGCACTTTCT-30 and 50-TCCACATCTCGCACGTCGGT-30; CD44
50-CTCTCCTGGCACTGGCTCTGATTC-30 and 50-GTCCGGGGTCTCT
GATGGTTCC-30. c-myc 50-AGCTCGCCCAAATCCTGTA-30 and 50-AG
CCCGACTCCGACCTCT-30.
GSK-3 Inhibition
Mice were injected i.p. with the GSK-3 inhibitors IX, X, and XII (Calbio-
chem, 361550), 15 mg per kg of body weight in 5% DMSO. After 6 hr
and 10 hr, mice were euthanized and organs were collected for subse-
quent analysis.
Isolation of Intestinal Crypts
Small intestinal crypts were isolated from adult male mice of 6–
12 weeks (Booth et al., 1999; Grossmann et al., 1998). The intestinal
segments were isolated, the lumenal contents were flushed out with
PBS, and the tissue was slit open longitudinally. After chopping into
5 mm pieces, the fragments were washed three times in PBS, 1
time in 10 mmol/l dithiothreitol/PBS (Sigma Chemical Co., St. Louis,
MO, USA) for 20 min and one time in 1 mmol/l EDTA (Sigma Chemical
Co., St. Louis, MO, USA) for 20 min. Epithelial cells were detached as
intact crypts and villus by ten vigorous shakes of the vessel. Large
pieces of intestine were then allowed to settle under gravity for
1 min, leaving the isolated crypts and villus in suspension. These
were removed and retained. The sedimented pellet was shaken vigor-
ously to release further crypts, resuspended in 45 ml PBS, and then
allowed to settle under gravity again. The suspended crypts and villus
were pooled with the original retained sample and then centrifuged at
300 rpm in a Sorvall Legend RT centrifuge. The step was repeated
three times until the supernatant appeared clear. The purified intestinal
Cell Stem Cell
Wip1/p53-Dependent Apoptosis of Intestinal Stem Cellsepithelial cells were divided into two parts. The first part was used for
protein extraction, subsequent electrophoresis, and western blotting
with antibody against p21Waf1, p53, and p38. The remaining material
was fixed in 4% paraformaldehyde for 1 hr at 4C, permeabilized using
0.5% Triton X-100 in PBS, and used for whole-mount immunofluores-
cent staining with anti-lysozyme antibody.
Label-Retaining Experiments
We performed juvenile labeling on mice aged between 36 and 45 days
postnatum (Potten et al., 2002). Mice were injected with 50 mCi [3H]thy-
midine (Amersham) i.p. twice daily for three consecutive days. All
animals were sacrificed 21 days after last injection. The intestinal
tissue was fixed (Carnoy’s and formalin). Sections were first immuno-
histochemically stained forWip1, active caspase-3, or TUNEL. Autora-
diography was undertaken using K5 emulsion (Iford Photo, Cheshire,
UK). The threshold for detecting label-retaining cells was set at ten
or more grains per nucleus.
Statistical Analysis
To assess the statistical significance of the results, each experiment
was repeated at least three times, means and standard deviations
between different groups were calculated, and error bars were
included where necessary. Student’s t test was performed for paired
analysis. Kaplan-Meier analysis of survival was performed with the
assistance of PRISM4 statistical analysis software.
Supplemental Data
Supplemental Data include two figures and can be found with this
article online at http://www.cellstemcell.com/cgi/content/full/1/2/
180/DC1/.
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